Extracellular Vesicle Therapy for Type 1 Diabetes
Research output: Contribution to journal › Review › Research › peer-review
Documents
- Fulltext
Final published version, 1.29 MB, PDF document
Type 1 diabetes (T1D) is a chronic disorder characterized by immune-mediated destruction of pancreatic insulin-producing β-cells. The primary treatment for T1D is multiple daily insulin injections to control blood sugar levels. Cell-free delivery packets with therapeutic properties, extracellular vesicles (EVs), mainly from stem cells, have recently gained considerable attention for disease treatments. EVs provide a great potential to treat T1D ascribed to their regenerative, anti-inflammatory, and immunomodulatory effects. Here, we summarize the latest EV applications for T1D treatment and highlight opportunities for further investigation.
Original language | English |
---|---|
Article number | 865782 |
Journal | Frontiers in Immunology |
Volume | 13 |
ISSN | 1664-3224 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
Publisher Copyright:
Copyright © 2022 Soltani, Mansouri, Emami Aleagha, Moasefi, Yavari, Shakouri, Notararigo, Shojaeian, Pociot and Yarani.
- exosomes, extracellular vesicle, immunomodulation, therapy, type 1 diabetes, β-cell
Research areas
ID: 305713545